Sean R Maloney1, Kathryn A Schlosser1, Tanushree Prasad1, Paul D Colavita1, Kent W Kercher1, Vedra A Augenstein1, B Todd Heniford2. 1. Division of Gastrointestinal and Minimally Invasive Surgery, Carolinas Hernia Center, Carolinas Medical Center, 1025 Morehead Medical Drive, Suite 300, Charlotte, NC, 28204, USA. 2. Division of Gastrointestinal and Minimally Invasive Surgery, Carolinas Hernia Center, Carolinas Medical Center, 1025 Morehead Medical Drive, Suite 300, Charlotte, NC, 28204, USA. Todd.Heniford@gmail.com.
Abstract
BACKGROUND: Component Separation (CST) typically involves incision of one or more fascial planes to generate myofascial advancement flaps to assist with fascial closure in ventral hernia repair (VHR). The aim of this study was to compare peri-operative outcomes and quality of life (QOL) after CST versus patients without CST (No-CST) in large, preperitoneal VHR (PPVHR). METHODS: A prospective, single institution hernia study examined all patients undergoing PPVHR with synthetic mesh. Emergency and contaminated operations were excluded. A case-control cohort was identified using propensity score matching for CST and No-CST. QOL was assessed using the Carolinas Comfort Scale. RESULTS: The algorithm matched 113 CST cases to 113 No-CST cases. The groups (CST vs No-CST) were similar regarding age, BMI, diabetes, smoking, defect size, mesh size, and follow-up. In univariate analysis, there was no difference in recurrence between the CST and no-CST groups (0.9% vs 0.9%, p = 1.0) or mesh infection (0.9% vs 0.0%, p = 1.0). CST did have more wound complications (29.2% vs 16.1%, p = 0.019). When controlling for panniculectomy and diabetes with multivariate logistic regression, CST continued to have had an increased risk for wound complications (OR 2.27, CI 1.16-4.47). QOL was routinely assessed. The groups were similar pre-operatively with 76.3% of CST patients and 77.8% of No-CST patients having pain (p = 1.0). At 1, 6, 12, 24, and 36 months post-operatively, the groups had equal QOL. CONCLUSION: The use of CST versus No-CST in the repair of large VHs results in an increased risk of wound complications but does not increase the hernia recurrence rate. In the largest QOL comparative study to date, CST's generation of myofascial advancement flaps does not negatively impact patient QOL in the repair of large ventral hernias in the short or long term.
BACKGROUND: Component Separation (CST) typically involves incision of one or more fascial planes to generate myofascial advancement flaps to assist with fascial closure in ventral hernia repair (VHR). The aim of this study was to compare peri-operative outcomes and quality of life (QOL) after CST versus patients without CST (No-CST) in large, preperitoneal VHR (PPVHR). METHODS: A prospective, single institution hernia study examined all patients undergoing PPVHR with synthetic mesh. Emergency and contaminated operations were excluded. A case-control cohort was identified using propensity score matching for CST and No-CST. QOL was assessed using the Carolinas Comfort Scale. RESULTS: The algorithm matched 113 CST cases to 113 No-CST cases. The groups (CST vs No-CST) were similar regarding age, BMI, diabetes, smoking, defect size, mesh size, and follow-up. In univariate analysis, there was no difference in recurrence between the CST and no-CST groups (0.9% vs 0.9%, p = 1.0) or mesh infection (0.9% vs 0.0%, p = 1.0). CST did have more wound complications (29.2% vs 16.1%, p = 0.019). When controlling for panniculectomy and diabetes with multivariate logistic regression, CST continued to have had an increased risk for wound complications (OR 2.27, CI 1.16-4.47). QOL was routinely assessed. The groups were similar pre-operatively with 76.3% of CSTpatients and 77.8% of No-CSTpatients having pain (p = 1.0). At 1, 6, 12, 24, and 36 months post-operatively, the groups had equal QOL. CONCLUSION: The use of CST versus No-CST in the repair of large VHs results in an increased risk of wound complications but does not increase the hernia recurrence rate. In the largest QOL comparative study to date, CST's generation of myofascial advancement flaps does not negatively impact patient QOL in the repair of large ventral hernias in the short or long term.
Authors: Laurel J Blair; Tiffany C Cox; Ciara R Huntington; Steven A Groene; Tanushree Prasad; Amy E Lincourt; Kent W Kercher; B Todd Heniford; Vedra A Augenstein Journal: Surg Endosc Date: 2016-12-30 Impact factor: 4.584
Authors: Cory N Criss; Clayton C Petro; David M Krpata; Christina M Seafler; Nicola Lai; Justin Fiutem; Yuri W Novitsky; Michael J Rosen Journal: Surgery Date: 2014-07 Impact factor: 3.982
Authors: Mary T Hawn; Stephen H Gray; Christopher W Snyder; Laura A Graham; Kelly R Finan; Catherine C Vick Journal: Am J Surg Date: 2011-07 Impact factor: 2.565
Authors: Stephanie Archer; Anna Pinto; Sabine Vuik; Colin Bicknell; Omar Faiz; Ben Byrne; Maximilian Johnston; Petros Skapinakis; Thanos Athanasiou; Charles Vincent; Ara Darzi Journal: Ann Surg Date: 2019-07 Impact factor: 12.969
Authors: B Todd Heniford; Amanda L Walters; Amy E Lincourt; Yuri W Novitsky; William W Hope; Kent W Kercher Journal: J Am Coll Surg Date: 2008-02-01 Impact factor: 6.113
Authors: Tiffany C Cox; Ciara R Huntington; Laurel J Blair; Tanushree Prasad; Amy E Lincourt; Brant T Heniford; Vedra A Augenstein Journal: Am J Surg Date: 2016-05-12 Impact factor: 2.565
Authors: B Todd Heniford; Samuel W Ross; Blair A Wormer; Amanda L Walters; Amy E Lincourt; Paul D Colavita; Kent W Kercher; Vedra A Augenstein Journal: Ann Surg Date: 2020-02 Impact factor: 12.969
Authors: Henning Niebuhr; Zaid Omar Malaibari; Ferdinand Köckerling; Wolfgang Reinpold; Halil Dag; Dietmar Eucker; Thomas Aufenberg; Panagiotis Fikatas; René H Fortelny; Jan Kukleta; Hansjörg Meier; Christian Flamm; Guido Baschleben; Marius Helmedag Journal: Chirurg Date: 2021-12-14 Impact factor: 0.955